PLA2G2A and metabolic syndrome: PLA2G2A is a known cartilage degradation enzyme and in serum has been shown to positively correlate with knee OA, but not to disease severity or MetS; the authors argued that this finding may be due to the inclusion of patients with end-stage disease undergoing arthroplasty [59].